105 results
Page 4 of 6
8-K
EX-99.12
oapu65 pmj
4 Sep 12
Other Events
12:00am
8-K
EX-99.14
c6qlkku21g7r0g3lvh43
4 Sep 12
Other Events
12:00am
8-K
p4p iw08ft1jh6u4d
22 May 12
Other Events
12:00am
8-K
EX-99.1
lae2f0uxds65i j9
22 May 12
Other Events
12:00am
8-K
EX-99.3
6k6z k1kddk3hitw51od
22 May 12
Other Events
12:00am
8-K
EX-99.4
8mdmc8kqtp0cyn vyj
22 May 12
Other Events
12:00am
8-K
EX-99.2
z79qoyf
22 May 12
Other Events
12:00am
8-K
EX-99
i2tyzlnva8qi8bb
26 Apr 12
Results of Operations and Financial Condition
12:00am
8-K
EX-99
xzahgbsbf1zz 8ri7rdx
27 Oct 11
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
vpsq9 ziwvryn85r4
26 Sep 11
Dose-related efficacy of GSK573719, a new long-acting muscarinic receptor antagonist (LAMA) offering sustained 24-hour bronchodilation in COPD
12:00am
8-K
EX-99.4
qysvvf3 cx
26 Sep 11
Dose-related efficacy of GSK573719, a new long-acting muscarinic receptor antagonist (LAMA) offering sustained 24-hour bronchodilation in COPD
12:00am
8-K
EX-99.2
5lr378ysg08iyvc4lk
26 Sep 11
Dose-related efficacy of GSK573719, a new long-acting muscarinic receptor antagonist (LAMA) offering sustained 24-hour bronchodilation in COPD
12:00am
8-K
eh0ay50nsylzt64n
26 Sep 11
Dose-related efficacy of GSK573719, a new long-acting muscarinic receptor antagonist (LAMA) offering sustained 24-hour bronchodilation in COPD
12:00am
8-K
EX-99.3
lmxgfv3
26 Sep 11
Dose-related efficacy of GSK573719, a new long-acting muscarinic receptor antagonist (LAMA) offering sustained 24-hour bronchodilation in COPD
12:00am
8-K
EX-99
jq6rl1
28 Jul 11
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
anpkg5obv7e4f24
17 May 11
Dose-related efficacy and optimal once-daily dosing interval of the long-acting beta2
12:00am
8-K
wie 6x7ucj2483p72
17 May 11
Dose-related efficacy and optimal once-daily dosing interval of the long-acting beta2
12:00am
8-K
EX-99
zy7sa2a8
21 Oct 10
Results of Operations and Financial Condition
12:00am
8-K
EX-99
8o6l3mz7qn
22 Sep 10
Other Events
12:00am